Peer Review History

Original SubmissionMay 28, 2019
Decision Letter - Gregory S. Barsh, Editor

Dear Dr Hu,

Thank you very much for submitting your Research Article entitled 'Minority-centric meta-analyses of blood lipid levels identify novel loci in the Population Architecture using Genomics and Epidemiology (PAGE) Study' to PLOS Genetics.

The manuscript was fully evaluated at the editorial level and by an independent peer reviewer. In general, PLOS Genetics seeks input from 3 or more peer reviewers, but we have been unable to secure additional reviewer comments despite many attempts to do so. The reviewer's comments have been assessed and considered by members of the editorial board; we agree with and fully support those comments, and have therefore decided to proceed with the single review in hand.

As you will see, the reviewer (and the editors) appreciate the attention to an important problem, but note that there are some substantial concerns about the current manuscript. We will not be able to accept this version of the manuscript, but we would be willing to review again a much-revised version. Many of the concerns will be straightforward to address, but please note that the concern regarding replication (point 2) is especially important and will need to be fully addressed for a revised manuscript to move forward.

Should you decide to revise the manuscript for further consideration here, your revisions should address the specific points made by each reviewer. We will also require a detailed list of your responses to the review comments and a description of the changes you have made in the manuscript.

If you decide to revise the manuscript for further consideration at PLOS Genetics, please aim to resubmit within the next 60 days, unless it will take extra time to address the concerns of the reviewers, in which case we would appreciate an expected resubmission date by email to plosgenetics@plos.org.

If present, accompanying reviewer attachments are included with this email; please notify the journal office if any appear to be missing. They will also be available for download from the link below. You can use this link to log into the system when you are ready to submit a revised version, having first consulted our Submission Checklist.

To enhance the reproducibility of your results, we recommend that you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see our guidelines.

Please be aware that our data availability policy requires that all numerical data underlying graphs or summary statistics are included with the submission, and you will need to provide this upon resubmission if not already present. In addition, we do not permit the inclusion of phrases such as "data not shown" or "unpublished results" in manuscripts. All points should be backed up by data provided with the submission.

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool.  PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org.

PLOS has incorporated Similarity Check, powered by iThenticate, into its journal-wide submission system in order to screen submitted content for originality before publication. Each PLOS journal undertakes screening on a proportion of submitted articles. You will be contacted if needed following the screening process.

To resubmit, use the link below and 'Revise Submission' in the 'Submissions Needing Revision' folder.

[LINK]

We are sorry that we cannot be more positive about your manuscript at this stage. Please do not hesitate to contact us if you have any concerns or questions.

Yours sincerely,

Gregory Barsh

Editor-in-Chief

PLOS Genetics

Gregory Copenhaver

Editor-in-Chief

PLOS Genetics

Reviewer's Responses to Questions

Comments to the Authors:

Please note here if the review is uploaded as an attachment.

Reviewer #1: Hu et al. present results of GWAS analyses of lipid profiles in ethnic minorities in the PAGE Consortium. They identified novel loci, some of which are driven by one ancestry, and/or are rare or monomorphic in Europeans. Some of the novel loci were replicated in additional published ethnic-specific and trans-ethnic studies. Allelic effects on lipids were not heterogeneous across ethnicities. Loci were interrogated for potential causal genes and fine-mapped to localise potential causal variants. The study is very timely, and the focus on the genetics of lipids in minority groups is extremely important. The messages about fine-mapping and use of multi-ethnic risk scores are very important to the human genetics research community. However, I have some concerns over the analytical approaches used.

1. Trait transformations. The authors state that lipid levels were inverse-normally transformed by sex. It was not clear to me whether this meant inverse-rank normalisation, or a Z-score transformation. In either case, this means that the effect estimates obtained for each study are NOT on the same scale, so it was not clear to me that a fixed-effects meta-analysis with inverse-variance weighting of effect sizes was appropriate, and that a Stouffer fixed-effects meta-analysis would be more appropriate. There are also no details (that I could find) on trait transformations in the replication sets, but again the same concern remains about effect size differences between studies.

2. Lack of replication. For several of the novel loci, there is very weak (if any) evidence of replication, even in ethnically matched components. I couldn’t find the sample sizes of the replication sets anywhere in the manuscript, but I’m assuming that they are substantially larger than PAGE? What is the explanation for this lack of replication – without this, I find it difficult to accept these associations as real.

3. Conditional analyses. These were performed using individual level data in PAGE, and approximate conditioning with GCTA in ENGAGE, but what was the reference used for LD.

4. The authors mention testing for heterogeneity in effects due to ethnicity by testing for interaction with PCs in PAGE, but I couldn’t find any information in the methods about this, nor any plots of PCs to demonstrate that this was an appropriate analysis/interpretation. Overall, I found the methods very sparse, and much more detail is needed to allow others to repeat experiments.

5. FINEMAP analyses. My understanding from reading the methods is that FINEMAP with first applied within each ethnic group, and then the results combined across ethnic groups. However, there are no details provided for the LD reference used for these analyses, and the parameter settings used, such as number of causal variants in a region. It is also not clear to me that combining the posterior probabilities across ethnicities as described is appropriate, so some justification of this approach is needed.

6. MTHFD2 locus. The authors highlight a SNP in strong LD with the index SNP, but it si not clear in which population group this LD is calculated? It would be more sensible to quote the relative posterior probability from the fine-mapping analysis, compared to the lead SNP – is it even in the 99% credible set? Similarly, I found listing SNPs that happened to have some interesting annotation that have r2>0.2 with an index SNP unimportant – again, it is not clear in which population the LD has been measured, or the relative posterior probabilities.

7. Table 2. It would be useful to have: MAF for each ethnic-specific analysis; the final combined meta-analysis p-value across discovery and replication; p-values to two significant figures throughout.

**********

Have all data underlying the figures and results presented in the manuscript been provided?

Large-scale datasets should be made available via a public repository as described in the PLOS Genetics data availability policy, and numerical data that underlies graphs or summary statistics should be provided in spreadsheet form as supporting information.

Reviewer #1: Yes

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Revision 1

Attachments
Attachment
Submitted filename: PAGE_lipids_rebuttal.docx
Decision Letter - Gregory S. Barsh, Editor

* Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. *

Dear Dr Hu,

Thank you very much for submitting your Research Article entitled 'Minority-centric meta-analyses of blood lipid levels identify novel loci in the Population Architecture using Genomics and Epidemiology (PAGE) Study' to PLOS Genetics. Your manuscript was fully evaluated at the editorial level and by independent peer reviewers.

The revised manuscript was seen by the original reviewer. As you will see, their comments are generally positive, but there are some remaining concerns that we ask you address in a hopefully final round of minor revision.

We therefore ask you to modify the manuscript according to the review recommendations before we can consider your manuscript for acceptance. Your revisions should address the specific points made by each reviewer.

In addition we ask that you:

1) Provide a detailed list of your responses to the review comments and a description of the changes you have made in the manuscript.

2) Upload a Striking Image with a corresponding caption to accompany your manuscript if one is available (either a new image or an existing one from within your manuscript). If this image is judged to be suitable, it may be featured on our website. Images should ideally be high resolution, eye-catching, single panel square images. For examples, please browse our archive. If your image is from someone other than yourself, please ensure that the artist has read and agreed to the terms and conditions of the Creative Commons Attribution License. Note: we cannot publish copyrighted images.

We hope to receive your revised manuscript within the next 30 days. If you anticipate any delay in its return, we would ask you to let us know the expected resubmission date by email to plosgenetics@plos.org.

If present, accompanying reviewer attachments should be included with this email; please notify the journal office if any appear to be missing. They will also be available for download from the link below. You can use this link to log into the system when you are ready to submit a revised version, having first consulted our Submission Checklist.

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org.

Please be aware that our data availability policy requires that all numerical data underlying graphs or summary statistics are included with the submission, and you will need to provide this upon resubmission if not already present. In addition, we do not permit the inclusion of phrases such as "data not shown" or "unpublished results" in manuscripts. All points should be backed up by data provided with the submission.

PLOS has incorporated Similarity Check, powered by iThenticate, into its journal-wide submission system in order to screen submitted content for originality before publication. Each PLOS journal undertakes screening on a proportion of submitted articles. You will be contacted if needed following the screening process.

To resubmit, you will need to go to the link below and 'Revise Submission' in the 'Submissions Needing Revision' folder.

[LINK]

Please let us know if you have any questions while making these revisions.

Yours sincerely,

Gregory Barsh

Editor-in-Chief

PLOS Genetics

Gregory Copenhaver

Editor-in-Chief

PLOS Genetics

Reviewer's Responses to Questions

Comments to the Authors:

Please note here if the review is uploaded as an attachment.

Reviewer #1: The authors have addressed most of my comments, and I believe the manuscript has been improved. However, I have a couple of outstanding comments...

1. I had not realised that the FINEMAP analysis had been performed assuming a single causal variant at each locus. Given this assumption, it is not clear why the authors have run FINEMAP, since this has been designed to allow for multiple causal variants at the locus. With a single causal variants, I believe that the LD reference is irrelevant, since no joint models with multiple SNPs are fitted. In theory, the association summary statistics for each ethnicity could just be used to calculate a Bayes' factor and posterior probability for each SNP. I think the methods should also state that the posterior probability calculation across ethnicities assumes that there is a single causal variant at the locus, and that this variant is the same in each ethnic group.

2. Heterogeneity assessment using SNP x PC interaction effect. I like this way of assessing heterogeneity due to ancestry, but wasn't clear why 10 PCs were used. Please provide justification. Including 10 PCs (if they are not needed) will substantially reduce power to detect heterogeneity (since an extra degree of freedom is needed for each PC in the test).

3. Tables still do not have p-values presented to two significant figures - Table 2 has a mixture of two and three significant figures (e.g. 4.89E-5 is three significant figures, 0.47 is two significant figures). I think all tables (including supplementary could do with proof reading) - e.g. in ST16, the causal allele frequency of rs11782435 is 2022%?

**********

Have all data underlying the figures and results presented in the manuscript been provided?

Large-scale datasets should be made available via a public repository as described in the PLOS Genetics data availability policy, and numerical data that underlies graphs or summary statistics should be provided in spreadsheet form as supporting information.

Reviewer #1: Yes

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Revision 2

Attachments
Attachment
Submitted filename: PAGE_lipids_rebuttal_R2.docx
Decision Letter - Gregory S. Barsh, Editor

Dear Dr Hu,

We are pleased to inform you that your manuscript entitled "Minority-centric meta-analyses of blood lipid levels identify novel loci in the Population Architecture using Genomics and Epidemiology (PAGE) Study" has been editorially accepted for publication in PLOS Genetics. Congratulations!

Before your submission can be formally accepted and sent to production you will need to complete our formatting changes, which you will receive in a follow up email. Please be aware that it may take several days for you to receive this email; during this time no action is required by you. Please note: the accept date on your published article will reflect the date of this provisional accept, but your manuscript will not be scheduled for publication until the required changes have been made.

Once your paper is formally accepted, an uncorrected proof of your manuscript will be published online ahead of the final version, unless you’ve already opted out via the online submission form. If, for any reason, you do not want an earlier version of your manuscript published online or are unsure if you have already indicated as such, please let the journal staff know immediately at plosgenetics@plos.org.

In the meantime, please log into Editorial Manager at https://www.editorialmanager.com/pgenetics/, click the "Update My Information" link at the top of the page, and update your user information to ensure an efficient production and billing process. Note that PLOS requires an ORCID iD for all corresponding authors. Therefore, please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field.  This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager.

If you have a press-related query, or would like to know about one way to make your underlying data available (as you will be aware, this is required for publication), please see the end of this email. If your institution or institutions have a press office, please notify them about your upcoming article at this point, to enable them to help maximise its impact. Inform journal staff as soon as possible if you are preparing a press release for your article and need a publication date.

Thank you again for supporting open-access publishing; we are looking forward to publishing your work in PLOS Genetics!

Yours sincerely,

Gregory S. Barsh

Editor-in-Chief

PLOS Genetics

Gregory Copenhaver

Editor-in-Chief

PLOS Genetics

www.plosgenetics.org

Twitter: @PLOSGenetics

----------------------------------------------------

Comments from the reviewers (if applicable):

----------------------------------------------------

Data Deposition

If you have submitted a Research Article or Front Matter that has associated data that are not suitable for deposition in a subject-specific public repository (such as GenBank or ArrayExpress), one way to make that data available is to deposit it in the Dryad Digital Repository. As you may recall, we ask all authors to agree to make data available; this is one way to achieve that. A full list of recommended repositories can be found on our website.

The following link will take you to the Dryad record for your article, so you won't have to re‐enter its bibliographic information, and can upload your files directly: 

http://datadryad.org/submit?journalID=pgenetics&manu=PGENETICS-D-19-00861R2

More information about depositing data in Dryad is available at http://www.datadryad.org/depositing. If you experience any difficulties in submitting your data, please contact help@datadryad.org for support.

Additionally, please be aware that our data availability policy requires that all numerical data underlying display items are included with the submission, and you will need to provide this before we can formally accept your manuscript, if not already present.

----------------------------------------------------

Press Queries

If you or your institution will be preparing press materials for this manuscript, or if you need to know your paper's publication date for media purposes, please inform the journal staff as soon as possible so that your submission can be scheduled accordingly. Your manuscript will remain under a strict press embargo until the publication date and time. This means an early version of your manuscript will not be published ahead of your final version. PLOS Genetics may also choose to issue a press release for your article. If there's anything the journal should know or you'd like more information, please get in touch via plosgenetics@plos.org.

Formally Accepted
Acceptance Letter - Gregory S. Barsh, Editor

PGENETICS-D-19-00861R2

Minority-centric meta-analyses of blood lipid levels identify novel loci in the Population Architecture using Genomics and Epidemiology (PAGE) Study

Dear Dr Hu,

We are pleased to inform you that your manuscript entitled "Minority-centric meta-analyses of blood lipid levels identify novel loci in the Population Architecture using Genomics and Epidemiology (PAGE) Study" has been formally accepted for publication in PLOS Genetics! Your manuscript is now with our production department and you will be notified of the publication date in due course.

The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript.

Soon after your final files are uploaded, unless you have opted out or your manuscript is a front-matter piece, the early version of your manuscript will be published online. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.

Thank you again for supporting PLOS Genetics and open-access publishing. We are looking forward to publishing your work!

With kind regards,

Matt Lyles

PLOS Genetics

On behalf of:

The PLOS Genetics Team

Carlyle House, Carlyle Road, Cambridge CB4 3DN | United Kingdom

plosgenetics@plos.org | +44 (0) 1223-442823

plosgenetics.org | Twitter: @PLOSGenetics

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .